Q3 2010

Filed Jul 21, 2011 · 10-Q · 51 days after period end · 0001303681-11-000151

Q3 2010 · 10-Q

Revenue—

Net Income

-$104.83K

no prior Q3 2009 on file

EPS Diluted

-$0.15

no prior Q3 2009 on file

Same quarter

no prior Q3 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended May 31, 2011 · filed Jul 21, 2011 · 51 d after period end

CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR